Hearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
(Adnkronos) – TÜBINGEN, Germany, Oct. 9, 2023 /PRNewswire/ — Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and
